₹ 181.00
0.20 (0.11%)
BSE
M
Mahamaya Lifesciences
₹ 181.00
BSE
MAHALIFE Financials Summary (Consolidated)
Mahamaya Lifesciences revenue stood at ₹118 Cr in Mar 2025 versus nil in the previous quarter, while net profit stood at ₹5 Cr versus nil in the previous quarter. EPS for the quarter stood at ₹3.04, increased from ₹0.00 in the previous quarter.
Mahamaya Lifesciences Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of MAHALIFE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
MAHALIFE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






